Visualitza per autor "Kim, Dong-Wan"
Ara mostrant els elements 1-2 d 2
-
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer
Chen, Joseph; bearz, alessandra; Kim, Dong-Wan; Mamdani, Hirva; Bauman, J. R.; chiari, rita; FELIP, ENRIQUETA (Springer, 2024-02) -
Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
Park, Keunchil; Jӓnne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Felip Font, Enriqueta (Wiley, 2021-05-01)